• Transactions
  • News
  • Events
  • Contact
  • SVB.com
  • Skip to primary navigation
  • Skip to main content
  • Skip to footer

SVB Leerink

Helping our clients move healthcare forward

  • Firm
    • About
    • Careers
    • News
  • Expertise
    • Investment Banking
    • Equity Research
    • Institutional Equities
    • Corporate Access
    • MEDACorp
  • Sectors
    • Biopharma
    • Medical Devices
    • Tools & Diagnostics
    • Healthcare Services
  • Log in
  • Transactions
  • News
  • Events
  • Contact
  • SVB.com

Helping Our Clients Move Healthcare Forward

A leading investment bank to the healthcare and life science industries.

Learn moreContact Us

Why Partner With Us

At SVB Leerink, we share a singular goal to achieve the highest level of success for our clients. We pride ourselves on being the most focused and passionate healthcare investment banking professionals in the industry.

Learn more

+835

Transactions Completed

since 2009Learn More

~$105

Billion Dollars
Raised

since 2009Learn More

~250

Companies Under Coverage

as of 12/31/2020Learn More

20K+

Global Network of Key Opinion Leaders

as of 12/31/2020Learn More

Our Expertise

We are champions of and strategic partners to those transforming the future of healthcare and life sciences. From startup to enterprise, we deliver the optimal solution for our clients comprised of capital, advisory, proprietary insights, sales and trading, and unique partnership with key opinion leaders.

Capital Markets

We are a market leader, partnering with innovative healthcare and life sciences companies throughout their financial life cycle.

Learn more

M&A Advisory

We leverage our long-term relationships, highly regarded sector knowledge, and transaction experience to deliver outcomes for our clients.

Learn more

Institutional Equities

Our singular focus on healthcare enables us to develop deep knowledge of the industry’s complex dynamics.

Learn more

Equity Research

Our team of industry leading equity research analysts provide in-depth and cutting-edge insights for companies and investors.

Learn more

MEDACorp

A global network of healthcare professionals that empowers us to uniquely guide our clients and deliver optimal results.

Learn more

Partner with us to achieve your strategic, capital markets and investment objectives.

Contact us

Healthcare Sectors

Our expertise, understanding, and knowledge of the healthcare and life sciences sectors make us the partner of choice for the industry.

Biopharma

Investors and corporate clients value SVB Leerink’s ability to assess the growth potential of innovative biopharma companies

Learn More

Medical Devices

We align with both emerging and established medical technology companies to be a trusted advisor in mergers and acquisitions, capital raising and strategic collaborations.

Learn more

Tools & Diagnostics

As the pace of progress in the tools & diagnostics sector continues to accelerate, our leading team of professionals is well positioned to advise and provide insight to our clients.

Learn more

Healthcare Services

Our healthcare services team has significant M&A and capital markets experience that enables us to bring exceptional knowledge and insight to our clients.

Learn more

Recent Transactions

See all transactions

$700 Million

Joint Bookrunner
Convertible Senior Notes
February 2021

$55 Million

Joint Bookrunner
Follow-On
February 2021

$175 Million

Joint Bookrunner
Follow-On
February 2021

$127 Million

Joint Bookrunner
Initial Public Offering
February 2021

$100 Million

Sole Bookrunner
Follow-On
February 2021

$75 Million

Sole Agent
At-The-Market (ATM) Facility
February 2021

$69 Million

Joint Bookrunner
Follow-On
February 2021

$550 Million

Joint Bookrunner
Follow-On
February 2021

$230 Million

Joint Bookrunner
Initial Public Offering
February 2021

$165 Million

Joint Bookrunner
Initial Public Offering
February 2021

$250 Million

Joint Bookrunner
Follow-On
February 2021

$261 Million

Joint Bookrunner
Follow-On
February 2021

Select Research

View additional research

Biopharma / Biotech Financing in a COVID Year: Record Deal Flow, Record Capital Formation

January 2021

Biopharma / Vax Series #4: Shibboleths – Short-Lived Immunity, Vaccine Scarcity, Local Mfg.

December 2020

Biopharma / COVID – The Beginning of the End as the Pieces Fall into Place

November 2020

Partner With Us

We deliver a complete suite of capital market and advisory solutions to help our clients define and achieve their strategic, capital market, and investment objectives.

Contact Us

Footer

Firm

  • About
  • Careers
  • Events
  • Privacy Notice
  • Important Disclosures

Expertise

  • Capital Markets
  • M&A Advisory
  • Institutional Equities
  • Equity Research
  • MEDACorp
  • Terms of Use

Sectors

  • Biopharma
  • Medical Devices
  • Tools & Diagnostics
  • Healthcare Services
  • Member FINRA/SIPC, www.finra.org

Other

  • News
  • Transactions
  • Contact
  • SVB.com
AN SVB COMPANY